Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XRAY
XRAY logo

XRAY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
10.445
Open
10.120
VWAP
10.28
Vol
5.32M
Mkt Cap
2.07B
Low
10.060
Amount
54.64M
EV/EBITDA(TTM)
7.30
Total Shares
200.33M
EV
4.12B
EV/OCF(TTM)
15.36
P/S(TTM)
0.56
DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
Show More

Events Timeline

(ET)
2026-06-11
09:30:00
Dentsply Sirona Appoints John Fortson as CFO
select
2026-05-05 (ET)
2026-05-05
16:20:00
Company Maintains FY26 Revenue Outlook of $3.5B-$3.6B
select
2026-05-05
16:20:00
Dentsply Sirona Reports Q1 Revenue of $880M
select
2026-05-04 (ET)
2026-05-04
17:10:00
Dentsply Sirona Announces New Agreement with Atlanta Dental Supply
select

News

Yahoo Finance
2.0
06-16Yahoo Finance
Three Small-Cap Stocks to Avoid
  • Dentsply Sirona's Poor Performance: Despite a market cap of $2.03 billion, Dentsply Sirona (XRAY) has seen disappointing revenue growth over the past two years, indicating weak demand, which has led to a 7.2% annual decline in earnings per share, negatively impacting investor confidence.
  • Navient's Sales Decline: With a market cap of $741.6 million, Navient (NAVI) has experienced a 21.3% annual drop in sales over the past five years, reflecting adverse market trends, and the decline in earnings per share raises concerns about its future performance among investors.
  • Increased Risks for Atlas Energy Solutions: Atlas Energy Solutions (AESI), valued at $2.06 billion, has a revenue base of $1.06 billion but is at a disadvantage compared to larger competitors, with its EBITDA margin falling by 29.6 percentage points, heightening investment risks.
  • Overall Small-Cap Risks: Small-cap stocks face higher downside risks due to their lack of scale and competitiveness, necessitating caution from investors to avoid significant losses amid market volatility.
NASDAQ.COM
5.0
06-11NASDAQ.COM
Dentsply Sirona Appoints New CFO
  • Executive Change: Dentsply Sirona announced the appointment of John Fortson as Chief Financial Officer and Executive Vice President, effective July 20, 2025, following the departure of the previous CFO, indicating the company's efforts to stabilize its executive leadership.
  • Leadership Experience: Fortson brings over 25 years of leadership experience in finance, operations, and strategy across public and private equity-backed companies, having most recently served as President and CFO of Kymera International, suggesting that his extensive background may provide new perspectives and strategic direction for Dentsply.
  • Market Reaction: On the day prior to the announcement, Dentsply's shares closed at $10.14 on Nasdaq, down 4.11%, reflecting a cautious market sentiment regarding the executive change, which could impact investor confidence.
  • Interim Leadership: Prior to Fortson's appointment, the company was under the interim leadership of Leslie Varon, highlighting the urgency and significance of the new CFO's role in guiding financial decisions and strategic execution during this transitional period.
seekingalpha
5.0
06-11seekingalpha
Dentsply Sirona Appoints New CFO
  • Executive Appointment: Dentsply Sirona announced the appointment of John Fortson as CFO effective July 20, bringing 13 years of experience as CFO or CEO in global manufacturing, which is expected to enhance the company's financial management capabilities.
  • Previous Experience: Before joining Dentsply, Fortson served as CFO at Kymera International and held various executive roles at Ingevity, including CFO, President, and board member, showcasing his extensive background in financial and operational management.
  • Financial Targets: Dentsply projects 2026 sales between $3.5 billion and $3.6 billion, with an EPS target of $1.40 to $1.50, indicating a positive outlook for future growth while aiming for approximately $120 million in annual savings through operational optimization.
  • Market Reaction: This appointment may bolster investor confidence in Dentsply, particularly as the company is undergoing strategic adjustments to meet its financial goals, with Fortson's addition seen as a crucial step towards enhancing the company's financial health.
Newsfilter
5.0
06-11Newsfilter
Dentsply Sirona Appoints New CFO John Fortson to Drive Growth Strategy
  • Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which will enhance the company's strategic perspective and capital markets expertise.
  • Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, significantly improving operational efficiency and financial discipline within the organization.
  • Strategic Growth Plan: CEO Dan Scavilla highlighted that Fortson's leadership style and strategic mindset will be instrumental in advancing the company's Return-to-Growth Action Plan, aimed at achieving long-term growth and shareholder value creation.
  • Financial Transformation Background: During his tenure at Ingevity Corporation, Fortson implemented a $700 million credit facility and a $300 million high-yield bond offering, strengthening the company's capital structure and demonstrating his capability in financial transformation.
PRnewswire
7.0
06-05PRnewswire
Investigation into Dentsply Sirona Shareholder Rights
  • Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers and directors of Dentsply Sirona Inc. breached their fiduciary duties, which could impact corporate governance and shareholder rights.
  • Legal Fee Arrangement: The firm operates on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal fees, thereby reducing financial barriers to participation and encouraging more shareholders to assert their rights.
  • Importance of Participation: Shareholder involvement can drive improvements in company policies, practices, and oversight mechanisms, enhancing transparency and accountability, which ultimately contributes to increased shareholder value and long-term company growth.
  • Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, showcasing their expertise in protecting investor rights.
Newsfilter
7.5
05-26Newsfilter
Dentsply Sirona Expands U.S. Distribution Network
  • Strengthened Partnership: Dentsply Sirona's partnership with Nashville Dental, Inc. will take effect on August 1, 2026, allowing NDI to distribute the full range of Dentsply Sirona's digital technology solutions across nine states, enhancing the company's market penetration in the Southeast and Mid-Atlantic regions.
  • Promotion of Digital Technologies: The collaboration with NDI will introduce Dentsply Sirona's CEREC system, Primescan intraoral scanners, and digital imaging solutions to more dental practices, addressing the growing demand for digital dentistry and driving the adoption of digitally connected workflows.
  • Localized Service Advantage: NDI, as a well-established full-service organization, provides support in equipment technology, installation, service, and practice advisory, ensuring that customers receive localized service and support when utilizing Dentsply Sirona's digital solutions, thereby enhancing customer satisfaction.
  • Market Strategy Optimization: This agreement underscores Dentsply Sirona's strategic focus in the U.S. market, aiming to enhance market accessibility through a balanced mix of direct and indirect channels, promoting the adoption of digital dental solutions and supporting the company's long-term growth objectives.
Wall Street analysts forecast XRAY stock price to rise
16 Analyst Rating
Wall Street analysts forecast XRAY stock price to rise
2 Buy
13 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
12.00
Averages
13.04
High
17.00
Current: 0.000
sliders
Low
12.00
Averages
13.04
High
17.00
Barclays
NULL -> Underweight
downgrade
$12 -> $9
AI Analysis
2026-06-04
Reason
Barclays
Price Target
$12 -> $9
AI Analysis
2026-06-04
downgrade
NULL -> Underweight
Reason
Barclays lowered the firm's price target on Dentsply Sirona to $9 from $12 and keeps an Underweight rating on the shares.
UBS
Buy
to
Buy
downgrade
$18 -> $17
2026-05-07
Reason
UBS
Price Target
$18 -> $17
2026-05-07
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Dentsply Sirona to $17 from $18 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for XRAY
Unlock Now

Valuation Metrics

The current forward P/E ratio for DENTSPLY SIRONA Inc (XRAY.O) is 7.32, compared to its 5-year average forward P/E of 14.62. For a more detailed relative valuation and DCF analysis to assess DENTSPLY SIRONA Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
14.62
Current PE
7.32
Overvalued PE
20.10
Undervalued PE
9.13

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
5.52
Current EV/EBITDA
8.81
Overvalued EV/EBITDA
31.97
Undervalued EV/EBITDA
-20.94

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.65
Current PS
0.57
Overvalued PS
2.41
Undervalued PS
0.89

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

todays top stocks to gain?
Intellectia · 57 candidates
Market Cap: >= 300.00MRegion: USPrice: $3.00 - $500.00Volume: >= 1,000,000Price Change Pct: >= $5.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
AAOI logo
AAOI
Applied Optoelectronics Inc
6.33B
ARLO logo
ARLO
Arlo Technologies Inc
1.68B
PRAA logo
PRAA
PRA Group Inc
605.63M
FIGS logo
FIGS
Figs Inc
2.57B
DELL logo
DELL
Dell Technologies Inc
98.13B
XRAY logo
XRAY
DENTSPLY SIRONA Inc
2.93B

Whales Holding XRAY

P
Paradigm Capital Management, Inc.
Holding
XRAY
+32.90%
3M Return
A
Armistice Capital LLC
Holding
XRAY
+17.03%
3M Return
A
Ariel Investments, LLC
Holding
XRAY
+8.40%
3M Return
C
Cooke & Bieler, L.P.
Holding
XRAY
+2.60%
3M Return
I
Invenomic Capital Management LP
Holding
XRAY
+2.03%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is DENTSPLY SIRONA Inc (XRAY) stock price today?

The current price of XRAY is 10.33 USD — it has increased 2.99

What is DENTSPLY SIRONA Inc (XRAY)'s business?

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

What is the price predicton of XRAY Stock?

Wall Street analysts forecast XRAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRAY is13.04 USD with a low forecast of 12.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is DENTSPLY SIRONA Inc (XRAY)'s revenue for the last quarter?

DENTSPLY SIRONA Inc revenue for the last quarter amounts to 880.00M USD, increased 0.11

What is DENTSPLY SIRONA Inc (XRAY)'s earnings per share (EPS) for the last quarter?

DENTSPLY SIRONA Inc. EPS for the last quarter amounts to -0.05 USD, decreased -150.00

How many employees does DENTSPLY SIRONA Inc (XRAY). have?

DENTSPLY SIRONA Inc (XRAY) has 14000 emplpoyees as of June 21 2026.

What is DENTSPLY SIRONA Inc (XRAY) market cap?

Today XRAY has the market capitalization of 2.07B USD.